Neutropenic Sepsis
• Definition: Fever ≥38°C and neutrophils <0.5 × 10⁹/L (or expected to fall)
• Common pathogens: Gram-negative bacilli (e.g., Pseudomonas),
Gram-positive cocci (e.g., coagulase-negative staph), Candida
• Initial management:
o Immediate empirical broad-spectrum IV antibiotics (do not wait for cultures)
o Example: piperacillin-tazobactam ± gentamicin
• Avoid:
o Rectal exams → mucosal injury → bacteraemia
o NSAIDs → mask fever, increase renal injury risk
Spinal Cord Compression
• Causes: vertebral metastases (breast, prostate, lung, myeloma)
• Key features:
o Severe back pain, worse when lying flat or with Valsalva
o Motor weakness, sensory level
o Urinary retention or incontinence, faecal incontinence
• Urgent management:
o High-dose IV dexamethasone (e.g., 16 mg/day) → reduce oedema
o MRI entire spine urgently
o Definitive treatment: surgical decompression or radiotherapy depending on prognosis and tumour type
Superior Vena Cava (SVC) Obstruction
• Causes:
o Lung cancer (especially small cell)
o Non-Hodgkin lymphoma
o Thrombosis (e.g., catheter-related)
• Clinical features:
o Facial, periorbital and upper limb swelling
o Dyspnoea, cough, orthopnoea
o Distended neck and chest wall veins ("collaterals")
o Headache, dizziness (cerebral congestion)
• Investigations:
o CXR: widened mediastinum
o CT thorax with contrast: assess cause, extent
• Management:
o Elevate head, oxygen
o Dexamethasone to reduce tumour oedema
o Endovascular stenting if severe symptoms
o Definitive treatment: chemotherapy (SCLC) or radiotherapy
Tumour Lysis Syndrome (TLS)
• At risk: high tumour burden, rapidly proliferating malignancies
o High-grade lymphomas (e.g., Burkitt)
o Acute leukaemias (especially ALL)
• Biochemical features:
o ↑ Potassium, ↑ phosphate, ↑ uric acid, ↓ calcium
• Complications:
o AKI (uric acid and calcium phosphate precipitation)
o Arrhythmias, seizures
• Prevention:
o Vigorous IV hydration
o Allopurinol (xanthine oxidase inhibitor) or rasburicase (urate oxidase; rapidly lowers uric acid)
• Treatment:
o Continue hydration
o Correct electrolytes
o Rasburicase if hyperuricaemia established
Hypercalcaemia of Malignancy
• Mechanisms:
o PTHrP secretion (squamous cell carcinoma)
o Bone metastases (breast, myeloma)
o Vitamin D production (lymphoma)
• Clinical features:
o Polyuria, polydipsia
o Dehydration, nausea
o Confusion, reduced consciousness
o Arrhythmias (short QT)
• Diagnosis: serum calcium >3.0 mmol/L often symptomatic
• Management:
o IV saline rehydration (restore volume, promote calciuresis)
o IV bisphosphonates (zoledronic acid or pamidronate)
o Consider calcitonin for rapid but temporary reduction
Key Extra Revision Points
Hyperviscosity syndrome
• Causes:
o Waldenström macroglobulinaemia (IgM)
o Multiple myeloma (high IgG or IgA)
• Clinical features:
o Visual disturbance ("sausage link" retinal veins)
o Headache, dizziness
o Bleeding diathesis (impaired platelet function)
• Treatment: plasmapheresis
SIADH (syndrome of inappropriate ADH)
• Causes:
o Small cell lung cancer (ectopic ADH)
o CNS disease (e.g., stroke, trauma, infection)
o Drugs: SSRIs, carbamazepine, cyclophosphamide
• Features:
o Euvolaemic hyponatraemia
o Confusion, seizures if severe
Multiple endocrine neoplasia (MEN)
• MEN 1 ("3 Ps"): pituitary, parathyroid, pancreatic tumours
• MEN 2A: medullary thyroid carcinoma, phaeochromocytoma, hyperparathyroidism
• MEN 2B: medullary thyroid carcinoma, phaeochromocytoma, mucosal neuromas, marfanoid habitus
• Screening and prophylactic thyroidectomy often required in RET mutations
Extra Pearls
• TLS → always check baseline uric acid and renal function before induction chemotherapy
• Bone metastases (breast, prostate) → bisphosphonates also help reduce skeletal events
• Hypercalcaemia → "stones, bones, groans, thrones, psychiatric overtones"